BBK Capital Partners »

Aeon Biopharma shares owned by BBK Capital Partners

Quarter-by-quarter ownership of Aeon Biopharma (AEON) shares owned by BBK Capital Partners from 13F filings

Historical chart of BBK Capital Partners investment in Aeon Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Aeon Biopharma held by BBK Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeon Biopharma by BBK Capital Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $419k 58k 7.20
2023-09-30 $360k 64k 5.60

More positions owned by BBK Capital Partners

Procter & Gamble Company (PG)
Apple (AAPL)
Etf Opportunities Trust Formidable Etf (FORH)
Etf Opportunities Trust Formidable Fortr (KONG)
Chevron Corporation (CVX)
Chemed Corp Com Stk (CHE)
Flux Pwr Hldgs (FLUX)
Microsoft Corporation (MSFT)
Eaton Vance Tax-Managed Global Dive Eq (EXG)
Meta Platforms Cl A (META)
Gamco Global Gold Nat Res & Com Sh Ben Int (GGN)
Acacia Resh Corp Acacia Tch Com (ACTG)
NVIDIA Corporation (NVDA)
Ishares Tr Core High Dv Etf (HDV)
Eaton V.Tax-Advantaged Dividend Inc Fund (EVT)

View all positions for BBK Capital Partners

Top funds holding Aeon Biopharma

Polar Securities
Atalaya Capital Management
Ikarian Capital
Vanguard Group
Alyeska Investment Group
BBK Capital Partners
Bank of America Corporation
Goldman Sachs Group
Jpmorgan Chase & Co
GHP Investment Advisors
UBS Group
Wells Fargo & Company
DuPont Capital Management Corporation

View all funds holding Aeon Biopharma